Restasis and Farxiga drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Farxiga (dapagliflozin). Common drug interactions include abscess among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Farxiga. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Farxiga?

Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. eHealthMe is studying from 18,798 Farxiga users. Check the latest studies of Farxiga.

On Jul, 23, 2026

38 people who take Restasis and Farxiga together, and have interactions are studied.

What are the common drug interactions of Restasis and Farxiga, by gender? *:

female:

Abscess (pus)
Abscess limb (limb infection)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Perirectal abscess
Rectal abscess (pus in rectum)
Haemolytic anaemia (anaemia due to haemolysis)
Malignant neoplasm of islets of langerhans (cancer tumour of pancreas)
Thyroid cancer
Weight decreased
Cartilage injury

male:

Cough
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Nasopharyngitis (inflammation of the nasopharynx)
Parkinsonian gait (gait exhibited by patients suffering from parkinson's disease)
Peripheral swelling
Sneezing
Swelling face
Asthenia (weakness)
Blood pressure decreased
Dizziness

What are the common drug interactions of Restasis and Farxiga, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Haemolytic anaemia (anaemia due to haemolysis)
Malignant neoplasm of islets of langerhans (cancer tumour of pancreas)
Thyroid cancer
Sepsis (a severe blood infection that can lead to organ failure and death)
Visual acuity reduced (reduced clearness of vision)

50-59:

Disease recurrence
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Dry mouth

60+:

Cough
Tremor (trembling or shaking movements in one or more parts of your body)
Rectal abscess (pus in rectum)
Back pain
Cardiac disorder
Dizziness
Dysstasia (difficulty in standing)
Fatigue (feeling of tiredness)
Hallucination (an experience involving the perception of something not present)
Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

Parkinson's Disease: 6 people, 15.79%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 15.79%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 4 people, 10.53%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 10.53%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 7.89%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.89%
Type 2 Diabetes: 2 people, 5.26%
Osteoporosis (bones weak and more likely to break): 2 people, 5.26%
Carcinoid Tumor: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Farxiga?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously